Skip to main content

Vaccine rollout will accelerate

China appears once again to have successfully crushed the recent COVID-19 flare-up. Its vaccination campaign is looking less impressive and the original target for inoculations by Lunar New Year appears to have been missed. But these are early days. Limited production capacity is unlikely to be a major constraint on the rollout for long. The Chinese people’s compliance with other pandemic control measures suggests that a vaccination drive would be effective. We expect the vaccination programme to expand rapidly over coming weeks.

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.


Free. 10 articles. No card required.

By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.